Related Experiment Videos
Direct plasma sample injection in multiple-component LC-MS-MS assays for high-throughput pharmacokinetic screening
1Stine Haskell Research Center, DuPont Pharmaceuticals Company, Newark, Delaware 19714, USA.
Analytical Chemistry
|February 3, 2000
Summary
A novel turbulent-flow, column-switching technique enables direct plasma injection for high-throughput drug screening. This method enhances speed and ruggedness in Liquid Chromatography-Mass Spectrometry-Mass Spectrometry (LC-MS-MS) assays, improving pharmacokinetic screening efficiency.
Area of Science:
- Analytical Chemistry
- Pharmacokinetics
- Drug Discovery
Background:
- High-throughput drug screening relies on simultaneous dosing and multi-component analysis (N-in-1 approach) using LC-MS-MS.
- Traditional plasma sample extraction is a bottleneck, limiting assay throughput in drug screening.
- N-in-1 LC-MS-MS assays require high sensitivity and excellent chromatographic separation to minimize interference and suppression effects.
Purpose of the Study:
- To develop a high-throughput on-line extraction technique for multiple-component LC-MS-MS assays.
- To enable direct plasma sample injection, bypassing traditional extraction limitations.
- To meet the high sensitivity and chromatographic separation requirements for N-in-1 LC-MS-MS assays in pharmacokinetic screening.
Main Methods:
- Development of a high-flow column-switching technique for on-line extraction.
- Direct injection of plasma samples containing multiple drug candidates onto an extraction column.
- Utilized turbulent-flow conditions for faster, more rugged extraction with reduced carryover.
- Elution of extracted analytes onto an analytical column for LC-MS-MS analysis via column switching.
Main Results:
- The turbulent-flow column-switching technique achieved high sensitivity and excellent chromatographic separation.
- Performance metrics (separation efficiency, dynamic range, accuracy, precision) were comparable to solid-phase extraction.
- Demonstrated reduced carryover and increased ruggedness compared to laminar-flow conditions.
Conclusions:
- The developed direct plasma injection method effectively addresses throughput limitations in N-in-1 LC-MS-MS assays.
- This turbulent-flow column-switching technique is suitable for high-throughput pharmacokinetic screening.
- The method successfully meets the stringent requirements for sensitivity and separation in complex biological matrices.